secwatch / observer
8-K filed June 13, 2024, 7:59 PM ET ticker OSRH CIK 0001840425
other material confidence high sentiment negative materiality 0.65

Two directors resign; Bellevue Life Sciences not compliant with Nasdaq listing rules

OSR Holdings, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Radclyffe Roberts

Member of the Board of Directors
OSRH · OSR Holdings, Inc.
Effective
2024-06-07
Filed
June 13, 2024, 7:59 PM ET
On June 7, 2024, Radclyffe Roberts also provided notice of his resignation as member of the Board and as a member of the Board’s Compensation Committee (the “Compensation Committee”) as well as a member and chair of the Board’s M&A Committee.
Departed

Inchul Chung

Member of the Board of Directors
OSRH · OSR Holdings, Inc.
Effective
2024-06-07
Filed
June 13, 2024, 7:59 PM ET
On June 7, 2024, Inchul Chung provided notice of his resignation as a member of the Board of Directors (the “Board”) of Bellevue Life Sciences Acquisition Corp. (the “Company”) and as a member of the Board’s Audit Committee (the “Audit Committee”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Radclyffe Roberts resigned as Member of the Board of Directors at OSR Holdings, Inc..

Action
resigned
Role
Member of the Board of Directors
Exact text from the filing
On June 7, 2024, Radclyffe Roberts also provided notice of his resignation as member of the Board and as a member of the Board’s Compensation Committee (the “Compensation Committee”) as well as a member and chair of the Board’s M&A Committee.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 1.0

Inchul Chung resigned as Member of the Board of Directors at OSR Holdings, Inc..

Action
resigned
Role
Member of the Board of Directors
Exact text from the filing
On June 7, 2024, Inchul Chung provided notice of his resignation as a member of the Board of Directors (the “Board”) of Bellevue Life Sciences Acquisition Corp. (the “Company”) and as a member of the Board’s Audit Committee (the “Audit Committee”).
View on SEC.gov

OSR Holdings, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-24-160727
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.